Background
Non-invasive ventilation (NIV) has become an integral tool in the management of
acute and chronic respiratory failure. Studies have shown that use of NIV decreases
the length of hospital stay, improves symptoms and also reduces the need for
invasive mechanical ventilation in patients with respiratory failure. However, NIV is
not used sufficiently in our country.
Objective
To find out the outcome of Non Invasive Ventilation in Respiratory failure in Nepal.
Methods
Retrospective analysis of data of 28 patients in between June 2010- November 2010
was done. All the patients selected had respiratory failure. Records were analysed
for documentation of clinical diagnosis. Arterial blood gases were assessed prior to,
after starting and after discontinuation of NIV. The outcome of NIV and the need for
domiciliary oxygen was evaluated at discharge.
Results
Thirty four patients received NIV out of which 6 were excluded from the study due
to insufficient documentation. Out of these 28 patients, 27 received bi-level and
one patient received Continuous Positive Airway Pressure. Mean age of patients
was 66.5 years and ranged from 42-87 years. Majority (19, 79%) were from age
group 60-80 years. Most common cause for the use of bi-level ventilation was
chronic obstructive pulmonary disease with type 2 respiratory failure in 19 patients
(67.8%). Others included obesity hypoventilation syndrome two, acute interstitial
pneumonia two, cardiogenic pulmonary oedema two, Interstitial lung disease one,
bronchogenic carcinoma one, and bronchiectasis one. Arterial blood gas analysis
was done on admission and 12 hours or earlier after the onset of bi-level ventilation.
At the time of admission, 89.3% of the patients had type 2 respiratory failure, of
which 60.6% had respiratory acidosis and 67.9% of patients had pCO2 above 60
mm Hg. Arterial blood pH prior to admission ranged from 7.19 to 7.50. Twelve
hours after bi-level ventilation, only 21.3% had pH <7.35 and 42.8% had pCO2
above 60 mm Hg. Non invasive ventilation was successful in 27 patients (96.4%).
All patients were advised domiciliary oxygen and all patients had respiratory follow
up arranged.
Conclusions
COPD patients with type 2 respiratory failure were seen to benefit most with NIV.
It is a very cost effective and safe method of treatment and should be used first in
patients with COPD with type 2 respiratory failure.
P.O.Box number: 11008, Kathmandu Nepal
Tel: +977-011-490497
Fax: +977-011-490707
Email:editor@kumj.com.np, kumj@kusms.edu.np